Endorphin deficiency syndrome (EDS) is a condition where low levels of natural opioids in the brain contribute to addictive behaviors. Endorphins play a vital role in regulating pain, stress, and mood. When deficient, individuals may turn to substances like alcohol or opioids to compensate, leading to dependency. This biological predisposition highlights the neurochemical foundation of addiction. Treatments often involve therapies that stimulate endorphin production, such as exercise, acupuncture, and certain antidepressants. Recognizing EDS in addiction patients is crucial for developing tailored interventions that address this underlying imbalance, improving treatment outcomes and reducing the likelihood of relapse.
Title : Tailoring biblio-poetry therapies using AI and biofeedback for addiction treatment
Nile Stanley, University of North Florida, United States
Title : The A-B-C of happiness coaching
Alphonsus Obayuwana, Triple-H Project LLC, United States
Title : Clinical pharmacology of marijuana: Update 2024
Frederick J Goldstein, Philadelphia College of Osteopathic Medicine, United States
Title : Trait-based recovery: Evidence-based trait activation to reduce depression, anxiety, and improve client engagement in addiction treatment
Jason Glenn Roop, The Center for Trait-Based Transformation, United States
Title : An investigation of the factors responsible for ubstance abuse from a cognitive perspective based on a mixed method approach
Adewole Olukorede, Literary Edifice, Italy
Title : A Long-Acting Naltrexone Implant (for Opioid Use Disorder: First-in-Human Phase I Trial)
Steven M Cohen, Akyso Therapeutics, United States